Approvals/CIMA-AEMPS/ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA

Approved

STANDARD

ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA

Glaxosmithkline Biologicals🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9a556f5421615852
Drug Cima Aemps Name: ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA
Register Number: 05330009IP3
Holder Company Name: Glaxosmithkline Biologicals
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/glaxosmithkline-biologicals
Authorization Date: 2022-11-03
Dosage Form: SUSPENSIÓN ORAL
Dose: 10 millones de germenes
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline Biologicals
Company Detail Path: /organization/glaxosmithkline-biologicals

ROTAVIRUS HUMANO

10 MILLONES GERMENES

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 3, 2022

Approval ID

9a556f5421615852

Type

Standard